OVERVIEW

Expert Debates on the Rise and Role of Biologics for Asthma is organized by Prime Education, LLC.

Release Date: Jun 03, 2019
Expiration Date: Jun 03, 2020

Intended Audience:
Physicians, Nurse Practitioners, Physician Assistants, Pharmacists, and Nurses

Accreditation:
Continuing Education Credits:
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

Physician Credit Designation Statement
PRIME designates this Enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™.

Physician Assistant Accreditation Statement
Physician assistants may receive a maximum of 1.5 hours of Category I credit for completing this program

Nurse Practitioner Accreditation Statement
This activity is approved for 1.5 contact hours of continuing education (which includes .3 hour of pharmacology) by the American Association of Nurse Practitioners

Pharmacist Accreditation Statement
This curriculum has been approved for 1.5 contact hours (0.15 CEUs) by PRIME.

Nurse Accreditation Statement
PRIME designates this activity for 1.5 contact hours.

Description:
This livestream recording of an engaging symposium, held at Asembia's 2019 Specialty Pharmacy Summit, brings refreshing perspectives for specialty pharmacy and managed care professionals on the latest advances that are shaping treatment for patients with moderate-to-severe asthma. Listen in as the expert panel engages in dynamic cross-fire debates on patient cases and applications of evidence to therapy selection and medication therapy management.

Additional details will be posted as soon as they are available.